Search clinical trials for: Topical testosterone gel 1.62 %

Total 369 results

Amneal Pharmaceuticals, LLC
Phase One Solutions, Inc.

Completed

Bioequivalence Study of Test and Reference Testosterone Topical Gel, 1.62% Metered Pump in Testosterone Deficient Adult Male Subjects Under Fasting Conditions

Hypogonadotropic Hypogonadism | Primary Hypogonadism

United States
Lipocine Inc.
PPD; Syneos Health

Completed

Safety and Efficacy of Oral LPCN 1021 in Men With Low Testosterone or Hypogonadism (SOAR)

Male Hypogonadism
Seattle Institute for Biomedical and Clinical Research

Recruiting

Improving Cancer-related Fatigue, Sexual Dysfunction and Quality of Life in Older Men With Cancer and Androgen Deficiency (TEMEC)

Cancer | Fatigue | Hypogonadism, Male

United States
Solvay Pharmaceuticals

Completed

Study of Serum Testosterone Levels in Non-dosed Females After Secondary Exposure

Hypogonadism

United States
AbbVie

Completed

An Open-Label Study of Serum Testosterone Levels in Non-dosed Females After Secondary Exposure to Testosterone Gel 1.62% Applied to the Upper Arms and Shoulders and Use of a T-shirt Barrier

Healthy
Boston Medical Center
National Institute on Aging (NIA)

Terminated

TOM: Testosterone in Older Men With Sarcopenia

Muscular Diseases | Sarcopenia | Hypogonadism

United States
Abbott

Completed

Testosterone Treatment for Hypogonadal Men

Hypogonadism
University of Washington

Completed

T-IR- Study to Understand the Effects of Testosterone and Estrogen on the Body's Response to the Hormone Insulin (T-IR)

Obesity | Type 2 Diabetes Mellitus | Insulin Resistance | Metabolic Disease | Androgen Deficiency

United States
AbbVie

Completed

A Study of the Effect of Topical Testosterone Replacement Therapy on Blood Pressure in Adult Male Participants With Hypogonadism

Hypogonadism

United States
VA Office of Research and Development

Recruiting

Testosterone Therapy and Bone Quality in Men With Diabetes and Hypogonadism

Type 2 Diabetes Mellitus | Hypogonadism

United States
AbbVie

Completed

Pharmacokinetic and Comparative Bioavailability Study of Testosterone Absorption After Administration of Testosterone Gel 1.62% to the Upper Arms/Shoulders Using an Application Site Rotation or a Combination of Application Sites in Hypogonadal Males

Hypogonadism
University Hospital, Clermont-Ferrand

Recruiting

Effects of Early Testosterone Gel Administration on Physical Performance in the Critically Ill (TestICUs)

Critical Illness

France
Clarus Therapeutics, Inc.
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center; PharmaN...

Completed

Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU) in Hypogonadal Men

Male Hypogonadism

United States, Germany
Novan, Inc.

Completed

Cutaneous Tolerability and Safety of NVN1000 Topical Gel in Healthy Volunteers

Acne Vulgaris

United States
Rhodes Pharmaceuticals, L.P.
ORA, Inc.

Completed

Safety and Efficacy of PG101 for Dry Eye Syndrome (PG101)

Dry Eye Syndrome

United States
Glia, LLC

Completed

Prolongation of Contact Lens Comfortable Wear Duration by CLM2 Topical Gel

Contact Lens Discomfort | Contact Lens-induced Corneal Disorder | Contact Lens Acute Red Eye | Contact Lens-induced Corneal Fluorescein Staining

United States
Novan, Inc.

Completed

A Phase 1, 3 Day Study of Safety and Tolerability of NVN1000 Topical Gel in Healthy Volunteers

Acne Vulgaris

United States
Ahmed A. H. Abdellatif

Unknown

Topical Silver Nanoparticles for Microbial Activity

Infection, Bacterial | Foot Infection Fungal

Saudi Arabia
Maruho Co., Ltd.

Completed

Pharmacodynamics, Safety/Tolerability and Efficacy of Topical Omiganan in Patients With uVIN

Usual Type Vulval Intraepithelial Neoplasia (uVIN)

Netherlands
Maruho Co., Ltd.

Completed

A Study to Evaluate the Safety and Efficacy of Omiganan (CLS001) Topical Gel Versus Vehicle in Female Subjects With Moderate to Severe Acne Vulgaris

Acne Vulgaris

United States
Maruho Co., Ltd.

Completed

Safety and Efficacy Study of CLS001Topical Gel Compared to Vehicle in Subjects With Inflammatory Acne Vulgaris

Acne Vulgaris

United States
Maruho Co., Ltd.
Leiden University Medical Center

Completed

Pharmacodynamics, Safety and Efficacy of Topical Omiganan in Patients With External Genital Warts

Condylomata Acuminata (External)

Netherlands
Lakewood-Amedex Inc
PrimeVigilance; Professional Education and Research Institute

Terminated

Nu-3 Topical Gel for Treatment of Diabetic Foot Ulcer

Chronic Diabetic Foot Ulcers

United States
Glia, LLC
ORA, Inc.

Completed

Treatment Safety and Efficacy of Pro-ocular™ 1% for Chronic Ocular Graft Following Allogeneic HSCT.

Chronic Ocular Graft-versus-host Disease

United States
University of Washington
National Institutes of Health (NIH); National Institute on Aging (NIA)

Completed

PROS-2 Dose Response Effects of Exogenous Testosterone on the Prostate (PROS-2)

Healthy

United States
Gulhane School of Medicine

Completed

Endothelial Dysfunction, Inflammation and Insulin Resistance in Congenital Hypogonadism and Effect of Testosteron Replacement Therapy

Hypogonadotrophic Hypogonadism

Turkey
Hovione Scientia Limited

Completed

Study to Evaluate the Safety and Efficacy of Topical Minocycline Gel in Patients With Papulopustular Rosacea

Rosacea | Papulopustular Rosacea

United States
PharmaDax Inc.
Glia, LLC

Enrolling by invitation

Treatment of Dry Eye Disease Using Pro-ocular™ - A Proof of Concept, Safety, and Efficacy Study

Keratoconjunctivitis Sicca | Dry Eye Syndrome

Taiwan
VA Office of Research and Development

Recruiting

Testosterone and Neural Function

Spinal Cord Injury

United States
BioSante Pharmaceuticals

Completed

Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)

Hypoactive Sexual Desire Disorder

United States, Canada
Biolab Sanus Farmaceutica

Withdrawn

Pharmacokinetics, Pharmacodinamic and Safety of Testosterone Gel 1%

Post-menopausal Period
Prism Pharma Co., Ltd.

Completed

Trial of Topical C-82 in Systemic Sclerosis - A Phase I/II Biomarker and Safety Trial

Systemic Scleroderma

United States
Kalypsys, Inc.

Completed

A 2 Week Study of Topical KD7040 in the Treatment of Postherpetic Neuralgia (PHN)

Neuropathic Pain | Herpes Zoster | Postherpetic Neuralgia | Shingles

United States
Kessler Foundation
United States Department of Defense

Unknown

TRT in Combination With Electrical Stimulation and Standing: Effect on Muscle and Bone in Spinal Cord Injured Males

Spinal Cord Injury

United States
Odense University Hospital

Unknown

Odense Androgen Study - The Effect of Testim and Training in Hypogonadal Men

Metabolic Syndrome | Hypogonadism

Denmark
BioMendics, LLC

Completed

Safety and Efficacy of Topical TolaSure Targeting Aggregated Mutant Keratin in Severe Epidermolysis Bullosa Simplex (TAMES)

Epidermolysis Bullosa Simplex

United States
BioMendics, LLC
Symbio, LLC

Completed

Efficacy of Topical TolaSure on Acute Induced Wounds in Healthy Participants

Wound Healing

United States
Abbott
Fovea

Completed

ESPRIT Study in Hypogonadal Men

Hypogonadism

Canada, Croatia, Germany, Kuwait, Romania, Russian Federation, Saudi Arabia, Slovenia, United Arab Emirates
University of Southern California
Solvay Pharmaceuticals

Completed

Effects of Testosterone Gel on Carbohydrate and Lipid Metabolism In Elderly Obese Men

Obesity | Insulin Resistance | Aging | Hypogonadism

United States
Peplin

Completed

A Multicenter Study to Evaluate the Safety and Efficacy of PEP005 Topical Gel When Used to Treat Actinic Keratoses on the Head (Face or Scalp)

Actinic Keratosis

United States, Australia
Acerus Pharmaceuticals Corporation

Completed

PK Study of Testosterone Nasal Gel (TBS-2) in Healthy Premenopausal Women

Female Sexual Dysfunction

United States
University of Washington
Eunice Kennedy Shriver National Institute of Child Health and Human Development...

Completed

CEP-1 Hormonal Regulation of Circulating Endothelial Progenitor Cells and HDL-C in Men (CEP-1)

Healthy
Hoth Therapeutics, Inc.
Worldwide Clinical Trials

Recruiting

Study to Investigate the Efficacy, Safety, and Tolerability of Topical HT-001 for the Treatment of Skin Toxicities Associated With Epidermal Growth Factor Receptor Inhibitors (CLEER)

Acneiform Eruption Due to Chemical | Xerosis Cutis | Paronychia

United States
University of Washington
National Institute on Aging (NIA); Solvay Pharmaceuticals

Completed

Hormone and Information Processing Study (HIP)

Mild Cognitive Impairment | Alzheimer's Disease

United States
Brigham and Women's Hospital

Recruiting

MED3000 Topical Gel for On-Demand Treatment of Post-Radical Prostatectomy Erectile Dysfunction

Erectile Dysfunction Following Radical Prostatectomy

United States
Peplin

Completed

Safety and Toleration of PEP005 Topical Gel When Applied to a Treatment Area of up to 100cm2

Actinic Keratosis

United States, Australia
University of Pennsylvania
Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaborators

Completed

The Testosterone Trials in Older Men

Andropause

United States
Gulhane School of Medicine

Completed

The Effect of Testosterone Replacement on the High Density Lipoprotein Cholesterol Subgroups

Secondary Hypogonadism

Turkey
Derm Research, PLLC

Completed

The Use of Onexton in Moderate Acne Vulgaris for Patients With Skin of Color

Acne Vulgaris | Post Inflammatory Hyperpigmentation

United States
BioMendics, LLC
University of Miami

Completed

Safety and Efficacy of Topical TolaSure on Skin Punch Biopsies in Healthy Participants

Wound Healing

United States

Search clinical trials for: Topical testosterone gel 1.62 %

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mozambique

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations